IL264692B2
Heterodimeric fc-fused cytokine and pharmaceutical composition comprising the same
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| US2010015089A1 | Cites | United States of America | Y | Search report | 1-17 |
| WO2014145907A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-17 |
47 members in 15 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 1020160101823 | Republic of Korea | – | |
| 20160101823 | Republic of Korea | A | |
| 1020170101594 | Republic of Korea | – | |
| 2017008676 | Republic of Korea | W | |
| 20170101594 | Republic of Korea | A |
Members47
| Document | Office | Kind | |
|---|---|---|---|
| CA3033475A1 | Canada | A1 | |
| WO2018030806A1 | World Intellectual Property Organization (WIPO) | A1 | |
| KR20180018419A | Republic of Korea | A | |
| AU2017310163A1 | Australia | A1 | |
| SG11201901071TA | Singapore | A | |
| IL264692A | Israel | A | |
| BR112019002394A2 | Brazil | A2 | |
| US2019169252A1 | United States of America | A1 | |
| EP3511340A1 | European Patent Office (EPO) | A1 | |
| MX2019001651A | Mexico | A | |
| CN110267977A | China | A | |
| KR102050463B1 | Republic of Korea | B1 | |
| KR20190134564A | Republic of Korea | A | |
| JP2019536734A | Japan | A | |
| EP3511340A4 | European Patent Office (EPO) | A4 | |
| US10696722B2 | United States of America | B2 | |
| US2020362004A1 | United States of America | A1 | |
| US2020362005A1 | United States of America | A1 | |
| JP2021088601A | Japan | A | |
| US11078249B2 | United States of America | B2 | |
| AU2017310163B2 | Australia | B2 | |
| MX386014B | Mexico | B | |
| MX2021010809A | Mexico | A | |
| AU2021273642A1 | Australia | A1 | |
| BR112019002394B1 | Brazil | B1 | |
| JP6993403B2 | Japan | B2 | |
| KR102416411B1 | Republic of Korea | B1 | |
| KR20220098108A | Republic of Korea | A | |
| JP7111855B2 | Japan | B2 | |
| JP2022137288A | Japan | A | |
| US11692019B2 | United States of America | B2 | |
| ZA201900772B | South Africa | B | |
| KR20230163339A | Republic of Korea | A | |
| KR102607285B1 | Republic of Korea | B1 | |
| US2023416325A1 | United States of America | A1 | |
| KR102652247B1 | Republic of Korea | B1 | |
| JP7488854B2 | Japan | B2 | |
| EP3511340B1 | European Patent Office (EPO) | B1 | |
| EP4470552A2 | European Patent Office (EPO) | A2 | |
| DK3511340T3 | Denmark | T3 | |
| ES3000558T3 | Spain | T3 | |
| EP4470552A3 | European Patent Office (EPO) | A3 | |
| AU2021273642B2 | Australia | B2 | |
| MX386014B | Mexico | B | |
| US12358964B2 | United States of America | B2 | |
| IL264692B1 | Israel | B1 | |
| IL264692B2This record | Israel | B2 |
Numbers
- Publication
- 264692
- Application
- 264692
Titles2
- English
- Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the same
- Hebrew
- ציטוקין הטרודימרי מאוחה ל- Fc ותכשיר רוקחי המכיל אותו
Classification
- CPC, 11
- C07K14/5434
- A61K38/20
- C07K14/54
- C07K14/59
- A61K38/00
- C07K2319/30
- A61P35/00
- Y02E60/10
- A61K38/24
- C07K2317/526
- A61K38/208
- IPC, 4
- A61K38 20
- A61K38 24
- C07K14 54
- C07K14 59